These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 28131494

  • 1. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection.
    van Gent R, Metselaar HJ, Kwekkeboom J.
    Transplant Rev (Orlando); 2017 Apr; 31(2):78-86. PubMed ID: 28131494
    [Abstract] [Full Text] [Related]

  • 2. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A, Manito N, Campistol JM, Cuervas-Mons V, Almenar L, Arias M, Casafont F, del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Serón D, Ussetti P, ATOS working group.
    Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
    [Abstract] [Full Text] [Related]

  • 3. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C, Pérez-Romero P, Blanco-Lobo P, Benmarzouk-Hidalgo OJ, Sánchez M, Gentil MA, Bernal C, Sobrino JM, Rodríguez-Hernández MJ, Cordero E, Spanish Network for Research in Infectious Diseases (REIPI).
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [Abstract] [Full Text] [Related]

  • 4. Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation.
    Snydman DR.
    Transpl Infect Dis; 2001 Oct; 3 Suppl 2():6-13. PubMed ID: 11926753
    [Abstract] [Full Text] [Related]

  • 5. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation.
    Dunn DL, Gillingham KJ, Kramer MA, Schmidt WJ, Erice A, Balfour HH, Gores PF, Gruessner RW, Matas AJ, Payne WD.
    Transplantation; 1994 Mar 27; 57(6):876-84. PubMed ID: 8154035
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.
    Rea F, Potena L, Yonan N, Wagner F, Calabrese F.
    Transplantation; 2016 Mar 27; 100 Suppl 3(Suppl 3):S19-26. PubMed ID: 26900991
    [Abstract] [Full Text] [Related]

  • 7. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L, Steinhoff J, Hartwig-Weber I, Bein G.
    Dtsch Med Wochenschr; 1997 May 02; 122(18):565-71. PubMed ID: 9190308
    [Abstract] [Full Text] [Related]

  • 8. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
    Varga M, Remport A, Czebe K, Péter A, Toronyi E, Sárváry E, Fehérvári I, Sulyok B, Járay J.
    Orv Hetil; 2008 Mar 23; 149(12):551-8. PubMed ID: 18343771
    [Abstract] [Full Text] [Related]

  • 9. Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation.
    Zamora MR.
    Transpl Infect Dis; 2001 Mar 23; 3 Suppl 2():49-56. PubMed ID: 11926751
    [Abstract] [Full Text] [Related]

  • 10. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
    Germer M, Herbener P, Schüttrumpf J.
    Ann Transplant; 2016 Sep 06; 21():558-64. PubMed ID: 27595792
    [Abstract] [Full Text] [Related]

  • 11. Resource utilization of cytomegalovirus immune globulin in prevention and treatment of cytomegalovirus infection in pediatric heart transplantation.
    Asante-Korang A, Carapellucci J, Krasnopero D, Brown B, Kiskaddon A, Wisotzkey B, Blyumin G, Berman DM, Namtu K.
    Clin Transplant; 2019 Dec 06; 33(12):e13750. PubMed ID: 31692121
    [Abstract] [Full Text] [Related]

  • 12. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM, Marquez MA, Bazerbachi F, Schiff JR, Cattral MS, McGilvray ID, Norgate A, Selzner M, Rotstein C, Husain S.
    Clin Transplant; 2013 Dec 06; 27(4):503-9. PubMed ID: 23731387
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus in transplantation - challenging the status quo.
    Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME.
    Clin Transplant; 2007 Dec 06; 21(2):149-58. PubMed ID: 17425738
    [Abstract] [Full Text] [Related]

  • 14. Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.
    Potena L, Solidoro P, Patrucco F, Borgese L.
    Expert Opin Pharmacother; 2016 Aug 06; 17(12):1611-22. PubMed ID: 27340928
    [Abstract] [Full Text] [Related]

  • 15. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.
    Ruttmann E, Geltner C, Bucher B, Ulmer H, Höfer D, Hangler HB, Semsroth S, Margreiter R, Laufer G, Müller LC.
    Transplantation; 2006 May 27; 81(10):1415-20. PubMed ID: 16732179
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
    Grossi P, Mohacsi P, Szabolcs Z, Potena L.
    Transplantation; 2016 Mar 27; 100 Suppl 3(Suppl 3):S1-4. PubMed ID: 26900989
    [Abstract] [Full Text] [Related]

  • 17. Viral prophylaxis in organ transplant patients.
    Slifkin M, Doron S, Snydman DR.
    Drugs; 2004 Mar 27; 64(24):2763-92. PubMed ID: 15563248
    [Abstract] [Full Text] [Related]

  • 18. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.
    Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD.
    Transpl Infect Dis; 2017 Dec 27; 19(6):. PubMed ID: 28921781
    [Abstract] [Full Text] [Related]

  • 19. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV.
    J Infect Dis; 2001 Dec 01; 184(11):1461-4. PubMed ID: 11709790
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J, Rotjanapan P, Watcharananan SP.
    Transplant Proc; 2017 Jun 01; 49(5):1048-1052. PubMed ID: 28583524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.